The relationship between TIGIT+ regulatory T cells and autoimmune disease

被引：28
|
作者：
Lee, Darren J. [1 ,2 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK 73107 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Dean McGee Eye Inst, Oklahoma City, OK 73190 USA
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2020年 / 83卷
基金：
美国国家卫生研究院;
关键词：
POLIOVIRUS RECEPTOR; INHIBITORY MOTIF; EXPRESSION; ADHESION; PROTEIN; DOMAIN; ENTEROPATHY; TOLERANCE; MECHANISM; NECTINS;
D O I：
10.1016/j.intimp.2020.106378
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The role of regulatory T cells (Treg cell) in controlling autoimmune disease is an area of intense study. As such, the characterization and understanding the function of Treg markers has the potential to provide a considerable impact in developing treatments and understanding the pathogenesis of autoimmune diseases. One such inhibitory Treg cell marker that has been recently discovered is T cell immunoglobulin and ITIM domain (TIGIT). In this review, we discuss what is known about the expression and function of TIGIT on Treg cells, and we discuss the relationship between TIGIT expressing Treg cells and different autoimmune diseases such as atopic dermatitis, autoimmune thyroiditis, type 1 diabetes, autoimmune uveitis, aplastic anemia, multiple sclerosis, systemic lupus erythematosus, arthritis, and colitis.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
    Riquelme, Paloma
    Haarer, Jan
    Kammler, Anja
    Walter, Lisa
    Tomiuk, Stefan
    Ahrens, Norbert
    Wege, Anja K.
    Goecze, Ivan
    Zecher, Daniel
    Banas, Bernhard
    Spang, Rainer
    Fandrich, Fred
    Lutz, Manfred B.
    Sawitzki, Birgit
    Schlitt, Hans J.
    Ochando, Jordi
    Geissler, Edward K.
    Hutchinson, James A.
    NATURE COMMUNICATIONS, 2018, 9
  • [2] Regulatory T cells: the future of autoimmune disease treatment
    Ryba-Stanislawowska, Monika
    Sakowska, Justyna
    Zielinski, Maciej
    Lawrynowicz, Urszula
    Trzonkowski, Piotr
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (07) : 777 - 789
  • [3] Upregulated TIGIT+ and Helios+ regulatory T cell levels in bronchoalveolar lavage fluid of NSCLC patients
    Lin, Fangnan
    Hu, Xintong
    Zhang, Yutong
    Ye, Suping
    Gu, Yue
    Yan, Bailing
    Wang, Lihui
    Jiang, Yanfang
    MOLECULAR IMMUNOLOGY, 2022, 147 : 40 - 49
  • [4] Regulatory T Cells and Inflammatory Mediators in Autoimmune Disease
    Gouirand, Victoire
    Habrylo, Ireneusz
    Rosenblum, Michael D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (3 PT B) : 774 - 780
  • [5] Implication of TIGIT+ human memory B cells in immune regulation
    Hasan, Md Mahmudul
    Nair, Sumi Sukumaran
    O'Leary, Jacqueline G.
    Thompson-Snipes, LuAnn
    Nyarige, Verah
    Wang, Junwen
    Park, Walter
    Stegall, Mark
    Heilman, Raymond
    Klintmalm, Goran B.
    Joo, HyeMee
    Oh, SangKon
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [6] The therapeutic potential of regulatory T cells for the treatment of autoimmune disease
    Bluestone, Jeffrey A.
    Trotta, Eleonora
    Xu, Daqi
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (08) : 1091 - 1103
  • [7] Frequencies of Regulatory CD8TIGIT T Cells Reflect Disease Status in COPD
    Hou, Jia
    Li, Hui
    Tian, Zhigang
    Zheng, Xiwei
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [8] Regulatory T cells in autoimmune neuroinflammation
    Kleinewietfeld, Markus
    Hafler, David A.
    IMMUNOLOGICAL REVIEWS, 2014, 259 (01) : 231 - 244
  • [9] Regulatory T cells in autologous stem cell transplantation for autoimmune disease
    van Wijk, F.
    Roord, S. T.
    Vastert, B.
    de Kleer, I.
    Wulffraat, N.
    Prakken, B. J.
    AUTOIMMUNITY, 2008, 41 (08) : 585 - 591
  • [10] The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies
    Muratori, Luigi
    Longhi, Maria Serena
    JOURNAL OF AUTOIMMUNITY, 2013, 46 : 74 - 80
12345